Research article
A randomized phase II study of carboplatin plus pegylated liposomal doxorubicin versus carboplatin plus paclitaxel in platinum sensitive ovarian cancer patients: a Hellenic Cooperative Oncology Group study
-
* Corresponding author: Helena Linardou elinardou@otenet.gr
BMC Medicine 2010, 8:3 doi:10.1186/1741-7015-8-3
No comments have yet been made on this article.